11,762
Total Claims
$1.3M
Drug Cost
799
Beneficiaries
$1,635
Cost/Patient
Peer Comparison vs. 110,156 Internal Medicine providers
+16%
Cost per patient vs peers
$1,635 vs $1,411 avg
+13%
Brand preference vs peers
12.0% vs 10.6% avg
Brand vs Generic
88% generic
Brand: 1,393 claims · $1.1M
Generic: 10,205 claims · $248K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 276 | $279K |
| Empagliflozin | 186 | $202K |
| Sitagliptin Phosphate | 154 | $168K |
| Linagliptin | 128 | $133K |
| Dulaglutide | 76 | $83K |
| Budesonide/Formoterol Fumarate | 71 | $40K |
| Atorvastatin Calcium | 1,325 | $22K |
| Umeclidinium Bromide | 38 | $19K |
| Ipratropium Bromide | 29 | $15K |
| Metoprolol Succinate | 464 | $13K |
| Valsartan | 241 | $12K |
| Amlodipine Besylate | 1,060 | $10K |
| Losartan Potassium | 538 | $10K |
| Fluticasone Propionate | 17 | $10K |
| Insulin Aspart Prot/Insuln Asp | 14 | $7,499 |
Prescribing Profile
Patient Profile
80
Avg Age
55%
Female
1.12
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data